Recommendations of the BSSO for patients with hepatobiliary cancers in the context of COVID-19 epidemic 2020

ABSTRACT

Since the first report in Hubei, China, COVID-19 rapidly spread throughout the world and the World Health Organization (WHO) declared COVID-19 as global Pandemic on March 11, 2020. The first confirmed case in Brazil was on February 26, 2020. These outbreaks pose a greater threat to patients with cancer in terms of morbidity and mortality as well as for the healthcare system professionals. The purpose of this editorial/letter is to provide specialist based recommendations for the treatment of hepatobiliary tumors during the pandemic period.

RESUMO

Desde o primeiro relatório em Hubei, China, a COVID-19 se espalhou rapidamente pelo mundo e a Organização Mundial da Saúde (OMS) declarou a COVID-19 como pandemia global em 11 de março de 2020. O primeiro caso confirmado no Brasil foi em 26 de fevereiro de 2020. Esses surtos representam uma ameaça maior para os pacientes com câncer em termos de morbimortalidade e também para os profissionais do sistema de saúde. O objetivo deste editorial/carta é fornecer recomendações baseadas em especialistas para o tratamento de tumores hepatobiliares durante o período de pandemia.

Keywords:

Coronavirus infections - Liver - Biliary tract neoplasms.

Descritores:

Melanoma - Terapia de modalidade combinada - Sistemas de saúde - Sistema único de saúde - Metástase neoplásica.

Publication History

Received: 02 June 2020

Accepted: 03 July 2020

Article published online:
14 May 2021

• REFERENCES

• Zhu N, Zhang D, Wang W, Li X, Yang B, Song J. et al A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; Feb; 382 (08) 727-733
• Ministério da Saúde (BR). COVID-19 - Painel coronavírus [Internet]. Brasília. DF: Ministério da Saúde;; 2020. access in 2020 Apr 10 Available from: https://covid.saude.gov.br/
• Ministério da Saúde (BR). Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Estimativa 2020: incidência de câncer no Brasil [Internet]. Rio de Janeiro, RJ: Ministério da Saúde/ INCA;; 2019. access in 2020 Apr 10 Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//estimativa-2020-incidencia-de-cancer-no-brasil.pdf
• Jazieh AR, Alenazi TH, Hejazi A, Al Safi F, Al Olayan A.. Outcome of oncology patients infected with coronavirus. J Glob Oncol 2020; Mar; 1 (06) 471-475 https://doi.org/10.1200/GO.20.00064
• Finlay IG, Meek D, Brunton F, McArdle CS.. Growth rate of hepatic metastases in colorectal carcinoma. Br J Surg 1988; Jul; 75 (07) 641-644 https://doi.org/10.1002/bjs.1800750707
• Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH.. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; Sep; 230 (03) 309-318 discussion:318-21
• Meijerink MR, Puijk RS, Van Tilborg AAJM, Henningsen KH, Fernandez LG, Neyt M. et al Radiofrequency and microwave ablation compared to systemic chemotherapy and to partial hepatectomy in the treatment of colorectal liver metastases: a systematic review and meta-analysis. Cardiovasc Intervent Radiol 2018; Apr; 41 (08) 1189204 https://doi.org/10.1007/s00270-018-1959-3
• Van Amerongen MJ, Jenniskens SFM, Van Den Boezem PB, Fütterer JJ, Wilt JHW.. Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases - a meta-analysis. HPB (Oxford) 2017; Sep; 19 (09) 749-756 https://doi.org/10.1016/j.hpb.2017.05.011
• Allard MA, Nishioka Y, Beghdadi N, Imai K, Gelli M, Yamashita S. et al Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases. BJS Open 2019; Oct; 3 (05) 678-686 https://doi.org/10.1002/bjs5.50174
• An C, Choi YA, Choi D, Paik YH, Ahan SH, Kim MJ. et al Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease. Clin Mol Hepatol 2015; Sep; 21 (03) 279-286 https://doi.org/10.3350/cmh.2015.21.3.279
• Lu MD, Kuang M, Liang LJ, Xie XY, Peng BG, Liu GJ. et al Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi 2006; Mar; 86 (12) 801-805
• Pompili M, Francica G, Ponziani FR, Iezzi R, Avolio AW.. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation. World J Gastroenterol 2013; Nov; 19 (43) 7515-7530
• De Rose AM, Cucchetti A, Clemente G, Ardito F, Giovannini I, Ercolani G. et al Prognostic significance of tumor doubling time in mass-forming type cholangiocarcinoma. J Gastrointest Surg 2013; Jan; 17 (04) 739-747 https://doi.org/10.1007/s11605-012-2129-6
• Giorgio A, Gatti P, Montesarchio L, Santoro B, Dell'Olio A, Crucinio N. et al Intrahepatic cholangiocarcinoma and thermal ablation: long-term results of an Italian retrospective multicenter study. J Clin Transl Hepatol 2019; 7 (04) 287-292 https://doi.org/10.14218/JCTH.2019.00036
• Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz J. et al Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; Ocy; 234 (04) 507-517 discussion:517-9
• Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, Khor CJL, Ponnudurai R, Moon JH. et al Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol 2013; Jan; 28 (04) 593-607 https://doi.org/10.1111/jgh.12128
• Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN.. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002; 137 (06) 675-681 https://doi.org/10.1001/archsurg.137.6.675
• Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN, James C. et al Preoperative portal vein embolization for extended hepatectomy. Ann Surg 2003; May; 237 (05) 686-693 https://doi.org/10.1097/01.SLA.0000065265.16728.C0
• Kanthan R, Senger JL, Ahmed S, Kanthan SC.. Gallbladder cancer in the 21st century. J Oncol 2015; Sep; 2015: 967472 https://doi.org/10.1155/2015/967472
• Sociedade Brasileira de Cirurgia Oncológica (SBCO). Vias livres de COVID-19 [Internet]. Rio de Janeiro. RJ: SBCO;; 2020. access in 2020 Apr 20 Available from: https://www.viaslivresdecovid.com/
• National Health Service (NHS). Speciality guides for patient management during the coronavirus pandemic Clinical guide for the management of non-coronavirus patients requiring acute treatment: cancer [Internet]. London. UK: NHS;; 2020. access in 2020 Apr 20 Available from: https://www.nice.org.uk/Media/Default/About/COVID-19/Specialty-guides/cancer-and-COVID-19.pdf